发明授权
US4201881A 24,24-Difluoro-1.alpha.,25-dihydroxycholecalciferol 失效
24,24-二氟-1α,25-二羟基胆钙化甾醇

24,24-Difluoro-1.alpha.,25-dihydroxycholecalciferol
摘要:
The invention provides new derivatives of vitamin D, 24,24-difluoro-1.alpha.,25-dihydroxycholecalciferol and 24,24-difluoro-1.alpha.,25-dihydroxy-5,6-trans-cholecalciferol and processes for preparing the same.The compounds are characterized by vitamin D-like activity essentially equivalent to the vitamin D-like activity of 1.alpha.,25-dihydrocholecalciferol which is considered to be the hormonal form and most active derivative of vitamin D. The compounds of this invention are characterized by their ability to increase intestinal calcium transport, increase serum calcium and to prevent the development of rickets. These compounds would find ready application as a substitute for vitamin D and in the treatment of disease states evincing metabolic calcium and phosphorus deficiencies.
公开/授权文献
信息查询
0/0